🇺🇸 FDA
Patent

US 8227473

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

granted A61KA61K31/4178A61K31/496

Quick answer

US patent 8227473 (Oxabicycloheptanes and oxabicycloheptenes, their preparation and use) held by Lixte Biotechnology, Inc. expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lixte Biotechnology, Inc.
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4178, A61K31/496, A61P, A61P25/00